Cisplatin treatment induces attention deficits and impairs synaptic integrity in the prefrontal cortex in mice.

The change in the expression of the postsynaptic glutamatergic marker PSD95 did not reach statistical significance, while expression of gephyrin was increased in cisplatin-treated mice (Fig. 8 ).

also in 111,027 other papers